Tofacitinib for the Treatment of Nail Lesions and Palmoplantar Pustulosis in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome

IMPORTANCE: Nail involvement is common in synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome, which has a strong association with quality of life in patients with SAPHO. Tofacitinib is an oral Janus kinase inhibitor that has been previously shown to be effective for nail psoria...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Dermatol
Autors principals: Li, Chen, Li, Zhaohui, Cao, Yihan, Li, Li, Li, Feng, Li, Yueting, Xiong, Dingkun, Wu, Xia, Zhang, Wen, Zeng, Xiaofeng
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2021
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7527944/
https://ncbi.nlm.nih.gov/pubmed/32997094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2020.3095
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars